Find Reports

Select Report Type

Reimbursement Review

Displaying 601 - 625 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Asunaprevir	Sunvepra	Asunaprevir	SR0418 Sunvepra.pdf SR0418_complete_Sunvepra_Jul-20_16.pdf SR0418_Sunvepra_CL_Report.pdf SR0418_Sunvepra_PE_Report.pdf SR0418_Sunvepra_PI_Submissions.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Feb 13, 2015	Jul 20, 2016	SR0418-000
dapagliflozin/metformin hydroc...	XigDuo	dapagliflozin/metformin hydrochloride	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original Patient Group Input Submissions Fixed‐Dose Combination Report Summary Report	Diabetes Mellitus, Type 2	Reimburse with clinical criteria and/or conditions	Complete	Jan 7, 2016	Jul 20, 2016	SR0468-000
Alirocumab	Praluent	Alirocumab	cdr_SR0469_Praluent.pdf SR0469_complete_Praluent_Jul-20-16.pdf SR0469_Praluent_CL_Report.pdf SR0469_Praluent_PE_Report.pdf SR0469_Praluent_PI_Submissions.pdf	Primary hypercholesterolemia (non-familial and heterozygous familial), mixed dyslipidemia	Reimburse with clinical criteria and/or conditions	Complete	Jan 12, 2016	Jul 20, 2016	SR0469-000
Imbruvica for Mantle Cell Lymp...	Imbruvica	Ibrutinib	pcodr-provfund_ibrutinib_imbruvica_mcl.pdf pcodr_ibrutinib_imbruvica_mcl_fn_rec.pdf pcodr_ibrutinib_imbruvica_mcl_fn_cgr.pdf pcodr_ibrutinib_imbruvica_mcl_fn_egr.pdf pcodr_ibrutinib_imbruvica_mcl_in_rec.pdf pcodr_ibrutinib_imbruvica_mcl_pagfdk.pdf pcodr_ibrutinib_imbruvica_mcl_fdk_janssen.pdf pcodr_ibrutinib_imbruvica_mcl_ptfdk_lfc.pdf pcodr_ibrutinib_imbruvica_mcl_ptfdk_llsc-ccsn.pdf pcodr_ibrutinib_imbruvica_mcl_coi_lfc.pdf pcodr_ibrutinib_imbruvica_mcl_coi_llsc-ccsn.pdf	Mantle Cell Lymphoma (relapsed/refractory)	Reimburse with clinical criteria and/or conditions	Complete	Jan 29, 2016	Jul 19, 2016	PC0073-000
Cotellic for Metastatic Melano...	Cotellic	Cobimetinib	pcodr_provfund_cobimetinib_cotellic_metmela.pdf pcodr_cobimetinib_cotellic_metmela_fn_rec.pdf pcodr_cobimetinib_cotellic_metmela_fn_cgr.pdf pcodr_cobimetinib_cotellic_metmela_fn_egr.pdf pcodr_cobimetinib_cotellic_metmela_in_rec.pdf pcodr_cobimetinib_cotellic_metmela_pagfdk.pdf pcodr_cobimetinib_cotellic_metmela_fdk_roche.pdf pcodr_cobimetinib_cotellic_metmela_ptgrpfdk.pdf pcodr_cobimetinib_cotellic_metmela_coi_mnc.pdf pcodr_cobimetinib_cotellic_metmela_coi_sysf.pdf	Metastatic melanoma	Reimburse with clinical criteria and/or conditions	Complete	Dec 11, 2015	Jun 30, 2016	PC0070-000
Kyprolis (with lenalidomide) f...	Kyprolis (with lenalidomide)	Carfilzomib (with lenalidomide)	pcodr_profund_10067carfilzomib_kyprolis_lenalidomide_mm.pdf pcodr_carfilzomib_kyprolis_mm_fn_rec.pdf pcodr_carfilzomib_kyprolis_mm_fn_cgr.pdf pcodr_carfilzomib_kyprolis_mm_fn_egr.pdf pcodr_carfilzomib_kyprolis_mm_in_rec.pdf pcodr_carfilzomib_kyprolis_mm_pagfdk.pdf pcodr_carfilzomib_kyprolis_mm_fdk_amgen.pdf pcodr_carfilzomib_kyprolis_mm_coi_mc.pdf	Multiple Myeloma	Reimburse with clinical criteria and/or conditions	Complete	Dec 11, 2015	Jun 21, 2016	PC0067-000
Canakinumab	Ilaris	Canakinumab	cdr_SR0463_Ilaris.pdf SR0463_Ilaris_sJIA_CL_Report.pdf SR0463_Ilaris_sJIA_PE_Report.pdf SR0463_complete_Ilaris_sJIA_June_21_16_e.pdf SR0463_Ilaris_SJIA_PI_Submissions.pdf	Systemic Juvenile Idiopathic Arthritis	Reimburse with clinical criteria and/or conditions	Complete	Dec 23, 2015	Jun 17, 2016	SR0463-000
dulaglutide	Trulicity	dulaglutide	Recommandation et motifs : Rapport mise à jour Submission Status Report Recommendation and Reasons: Original Clinical Report Pharmacoeconomic Report Patient Group Input Submissions	Diabetes mellitus, Type 2	Reimburse with clinical criteria and/or conditions	Complete	Dec 22, 2015	Jun 16, 2016	SR0462-000
Mepolizumab	Nucala	Mepolizumab	cdr_SR0461_Nucala.pdf SR0461_Nucala_CL_Report_e.pdf SR0461_Nucala_PE_Report_e.pdf SR0461_complete_Nucala_June-20-16_e.pdf SR0461_Nucala_PI_Submissions.pdf	Asthma, severe eosinophilic	Reimburse with clinical criteria and/or conditions	Complete	Dec 18, 2015	Jun 16, 2016	SR0461-000
Opdivo for Non-Small Cell Lung...	Opdivo	Nivolumab	pcodr_provfund_nivolumab_opdivo_nsclc.pdf nivolumab_opdivo_nsclc_fn_rec.pdf nivolumab_opdivo_nsclc_fn_cgr.pdf nivolumab_opdivo_nsclc_fn_egr.pdf nivolumab_opdivo_nsclc_in_rec.pdf nivolumab_opdivo_nsclc_pagfdk.pdf nivolumab_opdivo_nsclc_fdk_bms.pdf nivolumab_opdivo_nsclc_coi_lcc.pdf	Metastatic non small cell lung cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 29, 2015	Jun 3, 2016	PC0069-000
Elosulfase alfa	Vimizim	Elosulfase alfa	SR0456 Vimizim Resubmission.pdf SR0456_complete_Vimizim_May-26_16.pdf SR0456_Vimizim_Resubmission_CL_Report.pdf SR0456_Vimizim_Resubmission_PE_Report.pdf SR0456_Vimizim_Resubmission_PI_Submissions_Consolidated_validated.pdf	Mucopolysaccharidosis IVA (Morquio A syndrome)	Reimburse with clinical criteria and/or conditions	Complete	Nov 10, 2015	May 20, 2016	SR0456-000
Denosumab	Prolia	Denosumab	cdr_SF0453_Prolia.pdf SF0453_complete_RFA-Prolia_May-25-16_e.pdf SF0453_Prolia_RfA_Review_Report.pdf SF0453 Prolia_PI_Submissions.pdf	Osteoporosis	Reimburse with clinical criteria and/or conditions	Complete	Oct 26, 2015	May 20, 2016	SF0453-000
Elbasvir/grazoprevir	Zepatier	Elbasvir/grazoprevir	cdr_SR0454_grazoprevir_elbasvir.pdf SR0454_complete_Zepatier_May_25-16.pdf SR0454_Zepatier_CL_Report.pdf SR0454_Zepatier_PE_Report.pdf SR0454_grazoprevir+elbasvir_PI_Submissions_Consolidated_validated.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Oct 27, 2015	May 19, 2016	SR0454-000
ombitasvir/paritaprevir/ritona...	Holkira Pak	ombitasvir/paritaprevir/ritonavir and dasabuvir	cdr_SF0466_Holkira_Pak.pdf SF0466_complete_Holkira_Pak_May-25-16.pdf SF0466_HolkiraPak_RfA_Review_Report.pdf SF0466_HolkiraPak_RfA_PI_Submissions.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jan 6, 2016	May 19, 2016	SF0466-000
daclatasvir	Daklinza	daclatasvir	cdr_SF0467_Daklinza.pdf SF0467_complete_Daklinza_May_25-16.pdf SF0467_Daklinza_RfA_Review_Report.pdf SF0467_Daklinza_RfA_PI_Submissions.pdf	Hepatitis C, Chronic	Reimburse with clinical criteria and/or conditions	Complete	Jan 6, 2016	May 19, 2016	SF0467-000
Adalimumab	Humira	Adalimumab	SR0455 Humira HS.pdf SR0455_complete_Humira-HS_May-24-16_e.pdf SR0455_HumiraHS_CL_Report.pdf SR0455_HumiraHS_PE_Report.pdf SR0455 Humira HS - _PI_Submissions_Consolidated_validated.pdf	Hidradenitis suppurativa	Reimburse with clinical criteria and/or conditions	Complete	Nov 3, 2015	May 19, 2016	SR0455-000
Perampanel	Fycompa	Perampanel	SR0458 Fycompa PGTCS .pdf SR0458_complete_Fycompa_May-20-16_e.pdf SR0458_Fycompa_PGTCS_CL_Report.pdf SR0458_Fycompa_PE.pdf SR0458_Fycompa_PI_Submissions_Consolidated_validated.pdf	Epilepsy, primary generalized tonic-clonic seizures	Reimburse with clinical criteria and/or conditions	Complete	Nov 24, 2015	May 18, 2016	SR0458-000
ledipasvir, sofosbuvir	Harvoni	ledipasvir, sofosbuvir	SF0465 Harvoni.pdf SF0465_complete_Harvoni RFA_May_19-16.pdf SF0465_Harvoni_Hep_C_RfA_PI_Submissions.pdf SF0465_Harvoni_RfA_Review_Report.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jan 6, 2016	May 18, 2016	SF0465-000
sofosbuvir	Sovaldi	sofosbuvir	cdr_SF0464_Sovaldi.pdf SF0464_complete_Sovaldi-May_19_16.pdf SF0464_Sovaldi_RfA_Review_Report.pdf SF0464_Sovaldi_RFA_PI_Submissions.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Jan 6, 2016	May 18, 2016	SF0464-000
Omalizumab (Drug Plan Submissi...	Xolair	Omalizumab (Drug Plan Submission)	cdr_SR0457_Xolair_Resub.pdf SR0457_complete_Xolair_Resub-May_19_16.pdf SR0457_Xolair_Resub_PI_Submissions.pdf SR0457_Xolair_Resubmission_CL_Report_e.pdf SR0457_Xolair_Resubmission_PE_Report_e.pdf	Asthma, severe persistent	Reimburse with clinical criteria and/or conditions	Complete	Nov 18, 2015	May 18, 2016	SR0457-000
Avastin for Platinum-Resistant...	Avastin	Bevacizumab	pcodr-provfund_bevacizumab_avastin_proc.pdf pcodr_bevacizumab_avastin_proc_fn_rec.pdf pcodr_bevacizumab_avastin_proc_fn_egr.pdf pcodr_bevacizumab_avastin_proc_fn_cgr.pdf pcodr_bevacizumab_avastin_proc-in_rec.pdf pcodr_bevacizumab_avastin_proc_pagfdk.pdf pcodr_bevacizumab_avastin_proc_fdk_roche.pdf pcodr_bevacizumab_avastin_proc_ptfdk_occ.pdf pcodr_bevacizumab_avastin_proc_coi_occ.pdf	Platinum Resistant Ovarian Cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 29, 2015	May 5, 2016	PC0066-000
Dapagliflozin	Forxiga	Dapagliflozin	cdr_SR0445_Forxiga.pdf SR0445_complete_Forxiga-May_2_16-e.pdf SR0445_Forxiga_CL_Report.pdf SR0445_Forxiga_PE_Report.pdf	Diabetes mellitus, type 2	Do not list	Complete	Sep 4, 2015	Apr 27, 2016	SR0445-000
Sodium phenylbutyrate	Pheburane	Sodium phenylbutyrate	SR0452 Pheburane.pdf SR0452_complete_Pheburane-Apr-25_16-e.pdf SR0452_Pheburane_CL_Report.pdf SR0452_Pheburane_PE_Report.pdf	Urea cycle disorders	List	Complete	Oct 20, 2015	Apr 15, 2016	SR0452-000
Adalimumab	Humira	Adalimumab	cdr_SR0450_Humira.pdf SR0450_complete_Humira-Apr-19-16_e.pdf SR0450_Humira_UC_CL_Report.pdf SR0450_Humira_UC_PE_Report.pdf SR0450_Humira_UC_PI_Submissions.pdf	Ulcerative colitis	Do not list at the submitted price	Complete	Sep 25, 2015	Apr 15, 2016	SR0450-000
Insulin glargine	Basaglar	Insulin glargine	cdr_SE0451_Basaglar.pdf SE0451_complete_Basaglar-Apr_19-16-e.pdf SE0451_Basaglar_PI_Submissions.pdf SE0451_Basaglar_SEB_Report.pdf	Diabetes mellitus, type 1; diabetes mellitus, type 2	List with clinical criteria and/or conditions	Complete	Oct 5, 2015	Apr 14, 2016	SE0451-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 625 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Facial Analysis Technology for Pain Detection	Facial Analysis Technology for Pain Detection	Jul 31, 2023	Horizon Scan	Health Technology Update	Completed	EN0047-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Jul 31, 2023	Health Technology Review	Rapid Review	Completed	RC1491-000
Platelet-Rich Plasma Injections for Lower Back Pain	Platelet-Rich Plasma Injections for Lower Back Pain	Jul 31, 2023	Health Technology Review	Rapid Review	Completed	RC1485-000
An Overview of Clinical Applications of Virtual and Augmented Reality	An Overview of Clinical Applications of Virtual and Augmented Reality	Jul 31, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0111-000
CADTH Pharmaceutical Reviews Update — Issue 40		Jul 27, 2023	Reimbursement Review	Pharmaceutical Review Update
Multiple Myeloma	Final Report	Jul 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0031-000
Liraglutide for Pediatric Patients with Type 2 Diabetes	Liraglutide for Pediatric Patients with Type 2 Diabetes	Jul 26, 2023	Health Technology Review	Summary with Critical Appraisal	Completed	RC1494-000
Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates and Infants	Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates a…	Jul 26, 2023	Health Technology Review	Technology Review	Complete	HC0059-000
fostemsavir	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Jul 26, 2023	Reimbursement Review		Complete	SR0760-000
Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Jul 25, 2023	Health Technology Review	Summary of Abstracts	Completed	RB1673-000
selumetinib	Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Jul 24, 2023	Reimbursement Review		Complete	SR0764-000
daprodustat		Jul 24, 2023	Reimbursement Review		Withdrawn	SR0762-000
Xylazine Test Strips for Drug Checking	Xylazine Test Strips for Drug Checking	Jul 17, 2023	Horizon Scan	Health Technology Update	Completed	EN0049-000
Electrostimulation Devices for Wounds	Electrostimulation Devices for Wounds	Jul 17, 2023	Health Technology Review	Rapid Review	Completed	RC1489-000
Point-of-Care HIV and Syphilis Screening	Point-of-Care HIV and Syphilis Screening	Jul 13, 2023	Health Technology Review	Rapid Review	Completed	RC1490-000
caplacizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Jul 13, 2023	Reimbursement Review		Complete	SR0736-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Lower Extremities	Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Lower Extremities	Jul 10, 2023	Health Technology Review	Rapid Review	Completed	RC1486-000
Riluzole for Amyotrophic Lateral Sclerosis Treatment	Riluzole for Amyotrophic Lateral Sclerosis Treatment	Jul 7, 2023	Health Technology Review	Rapid Review	Completed	RC1487-000
Treatment of Adult Patients With Immune Thrombocytopenia After Failure of First-Line Therapies	Treatment of Adult Patients With Immune Thrombocytopenia After Failure of First…Project Protocol	Jul 6, 2023	Health Technology Review	Health Technology Assessment	Completed	HT0035-000
Hearing Aids and Dementia	Hearing Aids and Dementia	Jul 6, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0120-000
Rapid HIV Self-Testing	Rapid HIV Self-Testing	Jun 30, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0118-000
Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies	Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies	Jun 29, 2023	Health Technology Review	Rapid Review	Completed	RC1484-000
Adult B-Cell Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative and Positive	Final Report	Jun 28, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0030-000
Antimicrobial or Antiseptic Cleansers for Wounds	Antimicrobial or Antiseptic Cleansers for Wounds	Jun 28, 2023	Health Technology Review	Rapid Review	Completed	RC1488-000
mavacamten	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Jun 23, 2023	Reimbursement Review		Complete	SR0755-000